Gliosarcoma - 23 Studies Found
| Active, not recruiting |
: DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors : Glioblastoma or Gliosarcoma : 2014-07-20 :
|
| Completed |
: Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas :
: 2008-01-29 : Drug: Avastin and Temozolomide This is Phase II study with the combination of Avastin & Temozolomide |
| Withdrawn |
: Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma :
: 2015-11-04 :
|
| Completed |
: Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma :
: 2008-08-12 :
|
| Completed |
: Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma :
: 2007-09-04 :
|
| Completed |
: NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery :
: 2017-01-11 :
|
| Completed |
: Phase 1/2 Study in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients :
|
| Completed |
: Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma :
|
| Completed |
: Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas :
|
| Completed |
: BPM31510 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Previously Treated With Bevacizumab :
: 2017-01-05 :
|